Superior Vena Cava Flow in Children With Attention Deficit Hyperactivity Disorder

키워드

참고문헌 (46)

1. Polanczyk G, "The worldwide prevalence of ADHD : a systematic review and metaregression analysis", Am J Psychiatry, 164, pp.942~948 (2007)
2. Banaschewski T, "Attention-deficit", hyperactivity disorder, 2017, pp.114, 149~159
3. Grünblatt E, "Association study and a systematic meta-analysis of the VNTR polymorphism in the 3’-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder", J Neural Transm(Vienna), 126, pp.517~529 (2019)
4. da Silva N Jr, "Attention deficit", hyperactivity disorder : is there a correlation between dopamine transporter density and cerebral blood flow?, 2011, pp.36, 656~660
5. Madras BK, "The dopamine transporter and attention-deficit", hyperactivity disorder, 2005, pp.57, 1397~1409
6. Umair HM, "Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder(ADHD)and Raynaud’s phenomenon : a scoping review", Semin Arthritis Rheum, 51, pp.1200~1204 (2021)
7. Fulop GA, "Role of age-related alterations of the cerebral venous circulation in the pathogenesis of vascular cognitive impairment", Am J Physiol Heart Circ Physiol, 316, pp.H1124~H1140 (2019)
8. de Waal K, "Superior vena cava flow : role, assessment and controversies in the management of perinatal perfusion", Semin Fetal Neonatal Med, 25, pp.101122~ (2020)
9. Salim MA, "Contribution of superior vena caval flow to total cardiac output in children. A Doppler echocardiographic study", Circulation, 92, pp.1860~1865 (1995)
10. Osborn DA, "Low superior vena cava flow and effect of inotropes on neurodevelopment to 3 years in preterm infants", Pediatrics, 120, pp.372~380 (2007)
11. Hunt RW, "Low superior vena cava flow and neurodevelopment at 3 years in very preterm infants", J Pediatr, 145, pp.588~592 (2004)
12. Kaufman J, "Schedule for affective disorders and schizophrenia for school-age childrenpresent and lifetime version(K-SADS-PL) : initial reliability and validity data", J Am Acad Child Adolesc Psychiatry, 36, pp.980~988 (1997)
13. Ünal F, "Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 November 2016-Turkish Adaptation (K-SADSPL-DSM-5-T)", Turk Psikiyatri Derg, 30, pp.42~50 (2019)
14. Turgay A, "Disruptive behavior disorders : child and adolescent screening and rating scales for children, adolescents, parents and teachers" (1994), Michigan Integrative Therapy Institute Publication
15. Ercan ES, "Development of a test battery for the assessment of attention deficit hyperactivity disorder", Turk J Child Adolesc Ment Health, 8, pp.132~144 (2001)
16. Groves AM, "Echocardiographic assessment of blood flow volume in the superior vena cava and descending aorta in the newborn infant", Arch Dis Child Fetal Neonatal Ed, 93, pp.F24~F28 (2008)
17. Katzman MA, "A review of OROS methylphenidate(Concerta(®))in the treatment of attention-deficit", hyperactivity disorder, 2014, pp.28, 1005~1033
18. Modi NB, "Single-and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS(methylphenidate HCl)formulation", J Clin Pharmacol, 40, pp.379~388 (2000)
19. Gualtieri CT, "ADHD: is objective diagnosis possible?", Psychiatry(Edgmont), 2, pp.44~53 (2005)
20. Saad JF, "Is the theta", beta EEG marker for ADHD inherently flawed?, 2018, pp.22, 815~826
21. Schulz KP, "Response inhibition in adolescents diagnosed with attention deficit hyperactivity disorder during childhood : an event-related FMRI study", Am J Psychiatry, 161, pp.1650~1657 (2004)
22. Rubia K, "Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control : a study with functional MRI", Am J Psychiatry, 156, pp.891~896 (1999)
23. Bennett WF, "Anatomy of the superior vena cava and brachiocephalic veins", Thorac Surg Clin, 21, pp.197~203 (2011)
24. Egemen E, "Primer on cerebrovascular diseases", pp.32~36 (2017), Academic Press
25. Xing CY, "Distribution of cardiac output to the brain across the adult lifespan", J Cereb Blood Flow Metab, 37, pp.2848~2856 (2017)
26. Kluckow M, "Low superior vena cava flow and intraventricular haemorrhage in preterm infants", Arch Dis Child Fetal Neonatal Ed, 82, pp.F188~F194 (2000)
27. Katircioglu SF, "Comparison of metabolic responses to deep hypothermic total circulatory arrest and retrograde cerebral perfusion in an experimental model", Cardiovasc Surg, 10, pp.608~614 (2002)
28. Rodriguez RA, "Cerebral effects in superior vena caval cannula obstruction : the role of brain monitoring", Ann Thorac Surg, 64, pp.1820~1822 (1997)
29. Levy F, "Timing, space and ADHD : the dopamine theory revisited", Aust N Z J Psychiatry, 35, pp.504~511 (2001)
30. Gustafsson P, "Associations between cerebral blood-flow measured by single photon emission computed tomography(SPECT), electro-encephalogram(EEG), behaviour symptoms, cognition and neurological soft signs in children with attention-deficit hyperactivity disorder(ADHD)", Acta Paediatr, 89, pp.830~835 (2000)
31. Lee JS, "Regional cerebral blood flow in children with attention deficit hyperactivity disorder : comparison before and after methylphenidate treatment", Hum Brain Mapp, 24, pp.157~164 (2005)
32. Amen DG, "High-resolution brain SPECT imaging in ADHD", Ann Clin Psychiatry, 9, pp.81~86 (1997)
33. Spalletta G, "Prefrontal blood flow dysregulation in drug naive ADHD children without structural abnormalities", J Neural Transm(Vienna), 108, pp.1203~1216 (2001)
34. Kemp AH, "The relationship between mental and physical health : insights from the study of heart rate variability", Int J Psychophysiol, 89, pp.288~296 (2013)
35. Thayer JF, "Heart rate variability, prefrontal neural function, and cognitive performance : the neurovisceral integration perspective on self-regulation, adaptation, and health", Ann Behav Med, 37, pp.141~153 (2009)
36. Rukmani MR, "Heart rate variability in children with attention-deficit", hyperactivity disorder : a pilot study, 2016, pp.23, 81~88
37. Buchhorn R, "Heart rate variability and methylphenidate in children with ADHD", Atten Defic Hyperact Disord, 4, pp.85~91 (2012)
38. Hennissen L, "Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD : a systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine", CNS Drugs, 31, pp.199~215 (2017)
39. Arnsten AF, "Stimulants : therapeutic actions in ADHD", Neuropsychopharmacology, 31, pp.2376~2383 (2006)
40. Ayano G, "Dopamine : receptors, functions, synthesis, pathways, locations and mental disorders : review of literatures", J Ment Disord Treat, 2, pp.1000120~ (2016)
41. Yang Z, "D5 dopamine receptor regulation of phospholipase D", Am J Physiol Heart Circ Physiol, 288, pp.H55~H61 (2005)
42. Sibley DR, "Molecular neurobiology of dopaminergic receptors", Int Rev Neurobiol, 35, pp.391~415 (1993)
43. Chen YI, "Pharmacologic neuroimaging of the ontogeny of dopamine receptor function", Dev Neurosci, 32, pp.125~138 (2010)
44. Volkow ND, "Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain", J Neurosci, 21, pp.RC121~ (2001)
45. Schrantee A, "The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit", hyperactivity disorder, 2017, pp.13, 123~129
46. Lufi D, "Sport-based group therapy program for boys with ADHD or with other behavioral disorders", Child Fam Behav Ther, 33, pp.217~230 (2011)

관련 논문AI추천